On Nov 27, major Wall Street analysts update their ratings for $Agilent Technologies (A.US)$, with price targets ranging from $135 to $165.
J.P. Morgan analyst Rachel Vatnsdal maintains with a buy rating, and adjusts the target price from $165 to $160.
Citi analyst Patrick B Donnelly maintains with a buy rating, and maintains the target price at $165.
Wells Fargo analyst Brandon Couillard maintains with a buy rating, and adjusts the target price from $157 to $155.
Evercore analyst Vijay Kumar maintains with a hold rating, and adjusts the target price from $130 to $142.
TD Cowen analyst Daniel Brennan maintains with a buy rating, and maintains the target price at $160.
Furthermore, according to the comprehensive report, the opinions of $Agilent Technologies (A.US)$'s main analysts recently are as follows:
The ongoing improvements in instruments and biopharma are expected to contribute to an uplift in demand by 2025. However, the timing of stimulus impacts in China remains uncertain.
The company reported solid fiscal Q4 results with the launch of fiscal 2025 guidance aligning with buy-side expectations. Analysts assess that Agilent has started the year with achievable guidance, considering the prevailing geopolitical situation.
A consistent performance in Q4 along with conservative guidance for FY25 provides a solid basis for potential recovery. Following steady results and realistic expectations, a minor adjustment was made to the EPS forecasts, primarily owing to anticipated higher expenses.
Here are the latest investment ratings and price targets for $Agilent Technologies (A.US)$ from 9 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間11月27日，多家華爾街大行更新了$安捷倫科技 (A.US)$的評級，目標價介於135美元至165美元。
摩根大通分析師Rachel Vatnsdal維持買入評級，並將目標價從165美元下調至160美元。
花旗分析師Patrick B Donnelly維持買入評級，維持目標價165美元。
富國集團分析師Brandon Couillard維持買入評級，並將目標價從157美元下調至155美元。
Evercore分析師Vijay Kumar維持持有評級，並將目標價從130美元上調至142美元。
TD Cowen分析師Daniel Brennan維持買入評級，維持目標價160美元。
此外，綜合報道，$安捷倫科技 (A.US)$近期主要分析師觀點如下：
預計到2025年，儀器和生物製藥領域的持續改善將有助於需求的提升。然而，中國刺激政策影響的時機仍不確定。
公司報告顯示，財政第四季度表現穩健，2025財年指引的發佈符合買方的預期。分析師認爲，安捷倫已經開始了具有可實現性的指引，考慮到當前的地緣政治局勢。
第四季度的穩定業績以及對2025財年保守的指引爲潛在的復甦打下了堅實基礎。在穩定的業績和現實的預期之後，EPS預測進行了輕微調整，主要是因爲預計的支出增加。
以下爲今日9位分析師對$安捷倫科技 (A.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
